DRREDDY's weekly performance was relatively stable, with a modest return of 0.34% and a Sharpe Ratio of 0.18, indicating a slight positive risk-adjusted return. The stock's volatility was relatively low at 10.21%, and its Max Drawdown was contained at -0.59%. Compared to its peers, DRREDDY outperformed DIVISLAB, SUNPHARMA, and HINDUNILVR, which all posted negative returns. Overall, DRREDDY's performance was relatively risk-averse this week.

[Volatility: 10.21%]